Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 707.8 Million CNY | -1.66% |
| 2022 | 719.74 Million CNY | 13.9% |
| 2021 | 631.91 Million CNY | 7.07% |
| 2020 | 590.16 Million CNY | 13.55% |
| 2019 | 519.76 Million CNY | 5.42% |
| 2018 | 493.04 Million CNY | 19.56% |
| 2017 | 412.37 Million CNY | 7.2% |
| 2016 | 384.69 Million CNY | 43.83% |
| 2015 | 267.46 Million CNY | 48.37% |
| 2014 | 180.26 Million CNY | 14.38% |
| 2013 | 157.59 Million CNY | 64.06% |
| 2012 | 96.05 Million CNY | 3.83% |
| 2011 | 92.52 Million CNY | 43.29% |
| 2010 | 64.56 Million CNY | -22.88% |
| 2009 | 83.71 Million CNY | 160.26% |
| 2008 | 32.16 Million CNY | 274.58% |
| 2007 | 8.58 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 771.65 Million CNY | 15.42% |
| 2024 Q3 | 783.36 Million CNY | 1.52% |
| 2024 Q1 | 668.58 Million CNY | -5.54% |
| 2023 Q1 | 764.99 Million CNY | 6.29% |
| 2023 Q4 | 707.8 Million CNY | -3.05% |
| 2023 FY | 707.8 Million CNY | -1.66% |
| 2023 Q2 | 791.77 Million CNY | 3.5% |
| 2023 Q3 | 730.07 Million CNY | -7.79% |
| 2022 Q3 | 698.83 Million CNY | 1.81% |
| 2022 FY | 719.74 Million CNY | 13.9% |
| 2022 Q2 | 686.4 Million CNY | 4.32% |
| 2022 Q4 | 719.74 Million CNY | 2.99% |
| 2022 Q1 | 657.98 Million CNY | 4.12% |
| 2021 Q3 | 634.25 Million CNY | 2.77% |
| 2021 FY | 631.91 Million CNY | 7.07% |
| 2021 Q1 | 573.53 Million CNY | -2.82% |
| 2021 Q2 | 617.13 Million CNY | 7.6% |
| 2021 Q4 | 631.91 Million CNY | -0.37% |
| 2020 Q3 | 583.23 Million CNY | 3.44% |
| 2020 Q4 | 590.16 Million CNY | 1.19% |
| 2020 Q2 | 563.83 Million CNY | 4.24% |
| 2020 Q1 | 540.88 Million CNY | 4.06% |
| 2020 FY | 590.16 Million CNY | 13.55% |
| 2019 Q2 | 530.69 Million CNY | 8.51% |
| 2019 Q4 | 519.76 Million CNY | -2.57% |
| 2019 FY | 519.76 Million CNY | 5.42% |
| 2019 Q3 | 533.46 Million CNY | 0.52% |
| 2019 Q1 | 489.07 Million CNY | -0.8% |
| 2018 Q3 | 498.61 Million CNY | 9.98% |
| 2018 Q1 | 417.87 Million CNY | 1.33% |
| 2018 FY | 493.04 Million CNY | 19.56% |
| 2018 Q4 | 493.04 Million CNY | -1.12% |
| 2018 Q2 | 453.39 Million CNY | 8.5% |
| 2017 Q3 | 374.2 Million CNY | -4.51% |
| 2017 Q4 | 412.37 Million CNY | 10.2% |
| 2017 FY | 412.37 Million CNY | 7.2% |
| 2017 Q1 | 370.29 Million CNY | -3.74% |
| 2017 Q2 | 391.88 Million CNY | 5.83% |
| 2016 Q2 | 357.88 Million CNY | 44.63% |
| 2016 FY | 384.69 Million CNY | 43.83% |
| 2016 Q4 | 384.69 Million CNY | 6.05% |
| 2016 Q3 | 362.73 Million CNY | 1.36% |
| 2016 Q1 | 247.44 Million CNY | -7.48% |
| 2015 Q3 | 263.78 Million CNY | -8.66% |
| 2015 Q4 | 267.46 Million CNY | 1.4% |
| 2015 FY | 267.46 Million CNY | 48.37% |
| 2015 Q1 | 171.71 Million CNY | -4.74% |
| 2015 Q2 | 288.8 Million CNY | 68.18% |
| 2014 Q4 | 180.26 Million CNY | -5.8% |
| 2014 Q3 | 191.37 Million CNY | 1.59% |
| 2014 FY | 180.26 Million CNY | 14.38% |
| 2014 Q2 | 188.37 Million CNY | 19.64% |
| 2014 Q1 | 157.46 Million CNY | -0.09% |
| 2013 Q2 | 125.81 Million CNY | 19.1% |
| 2013 Q4 | 157.59 Million CNY | 8.21% |
| 2013 FY | 157.59 Million CNY | 64.06% |
| 2013 Q1 | 105.63 Million CNY | 9.97% |
| 2013 Q3 | 145.63 Million CNY | 15.76% |
| 2012 FY | 96.05 Million CNY | 3.83% |
| 2012 Q1 | 100.65 Million CNY | 8.8% |
| 2012 Q4 | 96.05 Million CNY | -5.84% |
| 2012 Q3 | 102.02 Million CNY | -15.32% |
| 2012 Q2 | 120.47 Million CNY | 19.69% |
| 2011 Q1 | 62.82 Million CNY | -2.7% |
| 2011 FY | 92.52 Million CNY | 43.29% |
| 2011 Q4 | 92.52 Million CNY | 7.83% |
| 2011 Q2 | 85.25 Million CNY | 35.71% |
| 2011 Q3 | 85.79 Million CNY | 0.64% |
| 2010 Q4 | 64.56 Million CNY | 0.0% |
| 2010 Q2 | 69.07 Million CNY | 0.0% |
| 2010 FY | 64.56 Million CNY | -22.88% |
| 2009 FY | 83.71 Million CNY | 160.26% |
| 2008 FY | 32.16 Million CNY | 274.58% |
| 2007 FY | 8.58 Million CNY | 0.0% |